反応式
[H-].[Na+].[Br:3][C:4]1[CH:5]=[C:6]2[C:10](=[CH:11][CH:12]=1)[NH:9][CH2:8][CH2:7]2.[CH3:13][S:14](Cl)(=[O:16])=[O:15]>CN(C=O)C>[Br:3][C:4]1[CH:5]=[C:6]2[C:10](=[CH:11][CH:12]=1)[N:9]([S:14]([CH3:13])(=[O:16])=[O:15])[CH2:8][CH2:7]2参加物
5
実験手順
To DMF (5.0 ml) was added sodium hydride (53 mg, 1.3 mmol) and the solution stirred at room temperature for 30 min. 5-Bromoindoline (240 mg, 1.2 mmol) was added and the solution was stirred at room temperature for 30 min. Methanesulfonyl chloride (94 ul, 1.2 mmol) was added and the solution stirred at room temperature overnight, then concentrated in vacuo. The crude product was purified by column chromatography on silica gel eluting with 2% CH3OH/CHCl3 to give the title compound (202 mg, 60%).
後処理
- stirringthe solution was stirred at room temperature for 30 min
- stirringthe solution stirred at room temperature overnight
- concentrationconcentrated in vacuo
- customThe crude product was purified by column chromatography on silica gel eluting with 2% CH3OH/CHCl3
出典と根拠
- ORDレコード
- ord-3b5425a03e9c4550bbe7b880e907f823
- 出典データセット
- uspto-grants-2015_08
- 特許番号
- US09095590B2
関連ノート
読み込み中…